In the wake of the December analyst day, Ligand Pharmaceuticals, Inc.’s (NASDAQ:LGND) partners have seen meaningful activity with another acquisition for Pelthos, a delay in Filspari’s Target Action ...

The broader cryptocurrency market remains under sustained pressure as bearish sentiment continues to dominate investor behavior. At the time of writing, the Crypto Fear & Greed Index stands at 24, ...